1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors – lessons learned from the PedNet prospective cohort study
- Contribution to journal › Article
- 2023
-
Mark
Haemophilia B - Diagnostic Insights, Genetic Aspects and Clinical Outcomes
(2023) In Lund University, Faculty of Medicine, Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
- Contribution to journal › Article
- 2021
-
Mark
The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B
- Contribution to journal › Article
- 2018
-
Mark
How I manage patients with inherited haemophilia A and B and factor inhibitors
- Contribution to journal › Scientific review
- 2016
-
Mark
Current view and outcome of ITI therapy : A change over time?
- Contribution to journal › Article
- 2010
-
Mark
Clinical issues in inhibitors
- Contribution to journal › Scientific review
- 2001
-
Mark
Therapeutic choices for patients with hemophilia and high-titer inhibitors
- Contribution to journal › Article
- 1998
-
Mark
Continuous infusion of factor IX concentrate to induce immune tolerance in two patients with haemophilia B
- Contribution to journal › Article
